IRIS
TUCCI, MARCO GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.185
AS - Asia 4.471
EU - Europa 3.159
SA - Sud America 1.124
AF - Africa 194
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.145
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.011
SG - Singapore 1.889
CN - Cina 888
BR - Brasile 858
HK - Hong Kong 577
IT - Italia 544
SE - Svezia 507
RU - Federazione Russa 448
DE - Germania 360
VN - Vietnam 322
FR - Francia 292
FI - Finlandia 270
GB - Regno Unito 211
UA - Ucraina 196
IN - India 160
ID - Indonesia 108
AR - Argentina 95
CA - Canada 89
BD - Bangladesh 87
IQ - Iraq 62
ZA - Sudafrica 54
PL - Polonia 50
MX - Messico 46
BE - Belgio 45
NL - Olanda 43
PK - Pakistan 42
CI - Costa d'Avorio 39
EC - Ecuador 39
AT - Austria 38
CO - Colombia 38
JP - Giappone 38
TR - Turchia 37
SA - Arabia Saudita 34
CL - Cile 33
PH - Filippine 32
MY - Malesia 27
ES - Italia 26
LT - Lituania 25
MA - Marocco 24
IE - Irlanda 22
UZ - Uzbekistan 21
VE - Venezuela 21
KE - Kenya 19
JO - Giordania 18
NP - Nepal 18
TN - Tunisia 17
PY - Paraguay 15
IR - Iran 12
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
KR - Corea 10
AL - Albania 9
CH - Svizzera 9
KZ - Kazakistan 9
OM - Oman 9
PE - Perù 9
CR - Costa Rica 8
GR - Grecia 8
UY - Uruguay 8
AU - Australia 7
EG - Egitto 7
ET - Etiopia 7
JM - Giamaica 7
IL - Israele 6
LB - Libano 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
PS - Palestinian Territory 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
HU - Ungheria 4
KW - Kuwait 4
SN - Senegal 4
TH - Thailandia 4
AM - Armenia 3
AO - Angola 3
BH - Bahrain 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PA - Panama 3
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
IS - Islanda 2
LY - Libia 2
MN - Mongolia 2
MR - Mauritania 2
NI - Nicaragua 2
RE - Reunion 2
Totale 18.111
Salva come PNG Salva come JPEG
Città #
Singapore 1.075
Ashburn 994
Fairfield 930
Chandler 699
Woodbridge 634
Hong Kong 570
San Jose 510
Jacksonville 427
Houston 418
Nyköping 407
Seattle 369
Cambridge 361
Beijing 309
Wilmington 300
Ann Arbor 269
Lauterbourg 176
Helsinki 168
Lawrence 151
Roxbury 149
New York 147
Dallas 133
Los Angeles 131
Nanjing 114
Des Moines 97
Bari 94
Ho Chi Minh City 91
Santa Clara 84
São Paulo 82
Jakarta 77
Council Bluffs 76
Princeton 76
Falkenstein 67
Hanoi 61
Inglewood 61
Boardman 60
Brooklyn 59
Munich 59
Buffalo 56
San Diego 48
Chicago 47
Warsaw 46
Brussels 44
Nuremberg 41
London 40
Abidjan 39
Paris 36
Frankfurt am Main 35
Redwood City 33
Dong Ket 31
Montreal 26
North Bergen 26
Shenyang 26
Tokyo 26
Milan 24
Rio de Janeiro 24
Rome 24
Chennai 23
Hebei 23
Nanchang 23
Denver 22
Dublin 22
Johannesburg 22
Stockholm 22
Baghdad 21
Mumbai 21
Orem 21
Dearborn 20
Toronto 20
Belo Horizonte 19
Tashkent 19
Amsterdam 18
Vienna 18
Dhaka 17
Moscow 17
Phoenix 17
Salt Lake City 17
Santiago 17
New Delhi 16
Quito 16
Amman 15
Atlanta 15
Columbus 15
Guangzhou 15
The Dalles 15
Tianjin 15
Cape Town 14
Curitiba 14
Da Nang 14
Marseille 14
Mexico City 14
Porto Alegre 14
San Mateo 14
Brasília 13
Nairobi 13
Ottawa 13
Poplar 13
Riyadh 13
Shanghai 13
Taranto 13
Buenos Aires 12
Totale 11.899
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 296
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 205
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 188
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 185
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine 185
Adenocarcinoma of the ceruminous glands: role of the VMAT 184
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology 177
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 177
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 176
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 171
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 170
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 170
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 167
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 167
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 166
Avβ3 integrin: Pathogenetic role in osteotropic tumors 166
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 161
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 159
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 157
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 156
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 152
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 150
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 148
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 148
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 144
Anemia in multiple myeloma: role of deregulated plasma cell apoptosis 143
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis 143
Cytotherapies in multiple myeloma: a complementary approach to current treatments 142
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis 139
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 138
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 137
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 136
Does cilengitide deserve another chance? 135
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 135
A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. 134
The clonal heterogenicity of circulating tumor cells (CTCs) drives their metastatic potential: a new NOD‐SCID melanoma model 132
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? 131
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 130
An update on Merkel cell carcinoma 129
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 129
AlphaVBeta3+ (AvB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 125
Recent advances in understanding the pathogenesis of anemia in multiple myeloma 125
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease 125
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 125
Successful treatment with apremilast of severe psoriasis exacerbation during nivolumab therapy for metastatic melanoma 124
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus 119
The day after mass COVID-19 vaccination: incidence of vaccine-related lymphadenopathy PET and impact on oncologic patients management 119
A functional polymorphism in the monocyte chemoattractant protein (MCP) - 1 promoter gene is strongly associated with lupus nephritis 118
[Malignant neoplasms and AIDS. Review of the literature and critical considerations on a case of epidermoid carcinoma of the anus]. FT Neoplasie maligne e AIDS. Rassegna della letteratura e considerazioni critiche su un caso di carcinoma epidermoide dell'ano. 118
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro 117
A new tool for the evaluation of disease activity in lupus nephritis: Urinary monocyte chemoattractant protein (MCP)-1. 117
Alpha(V)Beta(3) (alpha(v)beta(3)) integrin drives the osteoclastogenesis through a osteoclast-like functional differentiation of myeloma cells 117
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 117
Large extracellular vesicles—a new frontier of liquid biopsy in oncology 116
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. 115
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer 114
DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition 114
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 113
A role for fas-ligand in the pathogenesis and progression of multiple myeloma(MM). 113
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 113
Erratum for Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 111
A functional polymorphism in the monocyte chemoattractant protein (MCP)-1 promoter gene is strongly associated with lupus nephritis 110
Negative regulation of erythroblast maturation by Fas-L+/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma 110
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 110
miRNAs in melanoma: a defined role in tumor progression and metastasis 110
Severe anemia in a patient with vulvar melanoma 110
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients. 110
Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients 109
Induction of apoptosis by the hydrocarbon oil pristane: Implications for pristane-induced lupus 109
Massive hyper-progression during anti-PD1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review 109
Antiphosphatidylserine antibodies in human immunodeficiency virus-1(+) patients correlate with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 108
The immune escape in melanoma: role of the impaired dendritic cell function 106
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 105
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice 105
Prognostic factors and current treatment strategies for renal cell carcinoma metastatic to the brain: An overview 105
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 103
Alphavbeta3 (AVB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 103
null 103
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 103
Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia 102
Checkpoint Inhibitor-Induced Colitis: An Update 101
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. 101
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression 100
Increased IL-18 production by dendritic cells in active inflammatory myopathies 98
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis 98
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia 97
Is measurement of IL-10 useful for disease management in SLE? 96
The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis 96
Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors 96
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells 95
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 95
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 93
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer 93
Mast cells positive to c-kit receptor and to tryptase in normal to cancer pancreatic tissue and the correlation with angiogenesis. 93
Characterization of the metastatic behavior and gene expression profile (RNAseq) of different melanoma cell lines: a comprehensive in vivo model. 93
Th1 cytokines in the pathogenesis of lupus nephritis: The role of IL-18 92
Immunomodulation of T and B cell functions in multiple myeloma patients treated with combined erythropoietin and α-interferon therapy 92
L'eritropoietina umana nel trattamento dell'anemia associata al mieloma multiplo: potenziale effetto mitogeno sui linfociti B 91
VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease 91
Bone-Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both? 91
Totale 12.765
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.014
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021413 0 0 0 0 0 0 0 0 0 192 120 101
2021/20221.108 63 139 16 57 55 80 37 53 75 83 193 257
2022/20231.888 284 222 124 159 193 253 37 231 297 17 45 26
2023/2024680 62 127 41 102 64 114 20 33 9 18 15 75
2024/20253.310 134 38 285 160 95 271 336 288 172 216 427 888
2025/20266.523 1.055 341 448 776 801 442 848 246 896 670 0 0
Totale 18.776